ly 231617 has been researched along with Reperfusion Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clemens, JA; Panetta, JA | 1 |
| Clemens, JA; Little, SP; Panetta, JA; Smalstig, EB; Stephenson, DT; Yin, T | 1 |
2 other study(ies) available for ly 231617 and Reperfusion Injury
| Article | Year |
|---|---|
Novel antioxidant therapy for cerebral ischemia-reperfusion injury.
Topics: Animals; Antioxidants; Brain Ischemia; Butylated Hydroxytoluene; Male; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Thiazoles; Thiazolidines | 1994 |
Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappaB in rats.
Topics: Animals; Antioxidants; Butylated Hydroxytoluene; DNA-Binding Proteins; Hippocampus; NF-kappa B; Nuclear Proteins; Rats; Rats, Wistar; Reperfusion Injury; Time Factors; Transcriptional Activation | 1998 |